The OTC Markets is a software platform designed to display data. It relies entirely on the honesty of the disclosures uploaded by management. If a company uploads a clean spreadsheet, the platform gives them a green checkmark or an OTCID badge.
However, the platform does not audit the truth. If a retail investor digs into state registries and court dockets and finds out those disclosures are false, the market mechanics will eventually catch up, either via an SEC suspension, a downgrade to the Expert Market, or a total inability to execute corporate actions through FINRA.
To get an OTCID Basic Market status, a company must provide ongoing baseline financial disclosures and management certifications.
The OTC Markets Group is not a stock exchange, It is a private company that operates an Alternative Trading System (ATS). Is essentially an electronic bulletin board. It does not list stocks; it merely organizes and publishes quotes provided by Market Makers (broker-dealers like Citadel, Virtu, etc.) who are willing to trade the stock.
Under SEC Rule 15c2-11, broker-dealers are legally forbidden from publishing public buy/sell quotes for any company that does not maintain Current Public Information.
When an OTC company wants to execute a "catalyst" (like a merger, a reverse split, a name change, or moving to a new state), OTC Markets Group doesn't handle the corporate action. FINRA and the respective State Secretaries handle it.
If a state registry says the company is Forfeited or owes back-taxes, the state blocks the paperwork.
If the state blocks the paperwork, FINRA will not process the corporate action.
If FINRA won't process the action, the company cannot execute a merger, change its name, or issue clean new shares.
When OTC Markets Group receives a heavy, legally complex complaint (especially involving state-level forfeitures, multi-hundred-thousand-dollar judgments, and past disclosure fraud), they enter a bureaucratic phase that retail investors can't see.
They don't act like an internet moderator who deletes a post instantly. If they slap a Caveat Emptor (Skull and Crossbones) flag on a stock or downgrade its tier based on a third-party report, they open themselves up to massive lawsuits from the company for "tortious interference" or damages if they didn't follow strict due process.
When they receive a credible report, their internal legal team must verify the court dockets independently.
Once verified, they send a formal letter to the company’s executive management and the securities attorney who signed off on the filings. They typically give the company a 14 to 30 days window to formally respond, provide counter-evidence, or file an amended/corrected disclosure statement.
If Dr. Dalton or the company’s legal counsel received an inquiry from OTC Markets Compliance they won't just ignore it---they will use legal maneuvers to buy time.
Dr. Dalton might tell compliance: "We are currently in active discussions to settle the legacy judgments," or "We are preparing an amended filing to correct the disclosure omissions."
If Dr Dalton claims they are actively working to fix the issue, OTC Compliance will often hold off give them a window to upload the corrected paperwork.
If OTC Markets Group reviews the evidence and determines that the company has committed severe, willful disclosure fraud (rather than just an accidental omission), they don't always use the "Skull and Crossbones" flag right away. Sometimes, they hand the entire file directly over to the SEC’s Microcap Fraud Task Force or FINRA.
The SEC will build a case quietly behind the scenes for months. They wait until they have an ironclad case before they execute an unexpected, mid-day Trading Suspension.
A private trading bulletin board might take its time navigating the bureaucratic and legal steps required to enforce its guidelines, but the underlying legal realities do not change. The paperwork remains filed, the judgments remain outstanding, and the corporate gridlock remains active.
Disclaimer: The information provided above is for educational and informational purposes only and does not constitute formal legal, financial, or investment advice. All insights are based on publicly available corporate registries, court dockets, and financial disclosures.
PL
However, the platform does not audit the truth. If a retail investor digs into state registries and court dockets and finds out those disclosures are false, the market mechanics will eventually catch up, either via an SEC suspension, a downgrade to the Expert Market, or a total inability to execute corporate actions through FINRA.
To get an OTCID Basic Market status, a company must provide ongoing baseline financial disclosures and management certifications.
The OTC Markets Group is not a stock exchange, It is a private company that operates an Alternative Trading System (ATS). Is essentially an electronic bulletin board. It does not list stocks; it merely organizes and publishes quotes provided by Market Makers (broker-dealers like Citadel, Virtu, etc.) who are willing to trade the stock.
Under SEC Rule 15c2-11, broker-dealers are legally forbidden from publishing public buy/sell quotes for any company that does not maintain Current Public Information.
When an OTC company wants to execute a "catalyst" (like a merger, a reverse split, a name change, or moving to a new state), OTC Markets Group doesn't handle the corporate action. FINRA and the respective State Secretaries handle it.
If a state registry says the company is Forfeited or owes back-taxes, the state blocks the paperwork.
If the state blocks the paperwork, FINRA will not process the corporate action.
If FINRA won't process the action, the company cannot execute a merger, change its name, or issue clean new shares.
When OTC Markets Group receives a heavy, legally complex complaint (especially involving state-level forfeitures, multi-hundred-thousand-dollar judgments, and past disclosure fraud), they enter a bureaucratic phase that retail investors can't see.
They don't act like an internet moderator who deletes a post instantly. If they slap a Caveat Emptor (Skull and Crossbones) flag on a stock or downgrade its tier based on a third-party report, they open themselves up to massive lawsuits from the company for "tortious interference" or damages if they didn't follow strict due process.
When they receive a credible report, their internal legal team must verify the court dockets independently.
Once verified, they send a formal letter to the company’s executive management and the securities attorney who signed off on the filings. They typically give the company a 14 to 30 days window to formally respond, provide counter-evidence, or file an amended/corrected disclosure statement.
If Dr. Dalton or the company’s legal counsel received an inquiry from OTC Markets Compliance they won't just ignore it---they will use legal maneuvers to buy time.
Dr. Dalton might tell compliance: "We are currently in active discussions to settle the legacy judgments," or "We are preparing an amended filing to correct the disclosure omissions."
If Dr Dalton claims they are actively working to fix the issue, OTC Compliance will often hold off give them a window to upload the corrected paperwork.
If OTC Markets Group reviews the evidence and determines that the company has committed severe, willful disclosure fraud (rather than just an accidental omission), they don't always use the "Skull and Crossbones" flag right away. Sometimes, they hand the entire file directly over to the SEC’s Microcap Fraud Task Force or FINRA.
The SEC will build a case quietly behind the scenes for months. They wait until they have an ironclad case before they execute an unexpected, mid-day Trading Suspension.
A private trading bulletin board might take its time navigating the bureaucratic and legal steps required to enforce its guidelines, but the underlying legal realities do not change. The paperwork remains filed, the judgments remain outstanding, and the corporate gridlock remains active.
Disclaimer: The information provided above is for educational and informational purposes only and does not constitute formal legal, financial, or investment advice. All insights are based on publicly available corporate registries, court dockets, and financial disclosures.
PL
2
